Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma

Molecular Cancer Research

Volumn 11, Issue 4, 2013, Pages 349-359

  Daft, Paul G ^a   Yuan, Kaiyu ^a   Warram, Jason M ^b   Klein, Michael J ^c   Siegal, Gene P ^a   Zayzafoon, Majd ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 2; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; BONE NEOPLASMS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE SILENCING; HUMANS; MALE; MICE; MICE, NUDE; OSTEOSARCOMA; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84876528712     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0572     Document Type: Article

References (45)

1. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I, Papavassiliou AG. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 2003;32:364-71. (Pubitemid 36407536)
2. Bielack SS, Carrle D, Hardes J, Schuck A, Paulussen M. Bone tumors in adolescents and young adults. Curr Treat Options Oncol 2008;9: 67-80.
3. Skubitz KM, D'Adamo DR. Sarcoma. Mayo Clin Proc 2007;82: 1409-32. (Pubitemid 350060138)
4. Tang N, Song WX, Luo J, Haydon RC, He TC. Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 2008; 466:2114-30.
5. Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004;9:422-41. (Pubitemid 39014554)
6. Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis 2007;2:6.
7. Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997;15:76-84. (Pubitemid 27020560)
8. Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol 2003;14:1126-34. (Pubitemid 36950179)
9. Soderling TR, Chang B, Brickey D. Cellular signaling through multifunctional Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 2001;276:3719-22.
10. Tsui J, Inagaki M, Schulman H. Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation. J Biol Chem 2005;280:9210-6. (Pubitemid 40409611)
11. Riganti C, Doublier S, Viarisio D, Miraglia E, Pescarmona G, Ghigo D, et al. Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression. Br J Pharmacol 2009;156:1054-66.
12. Mamaeva OA, Kim J, Feng G, McDonald JM. Calcium/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells. J Cell Biochem 2009;106:25-32.
13. Hishinuma S, Ogura K. Ca(2+)/calmodulin-mediated regulation of the desensitizing process in G(q) protein-coupled histamine H(1) receptor-mediated Ca(2+) responses in human U373 MG astrocytoma cells. J Neurochem 2000;75:772-81. (Pubitemid 30485460)
14. Zayzafoon M, Fulzele K, McDonald JM. Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression. J Biol Chem 2005;280:7049-59. (Pubitemid 40341261)
15. Yuan K, Chung LW, Siegal GP, Zayzafoon M. alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression. Lab Invest 2007;87:938-50. (Pubitemid 47267818)
16. Choo MK, Yeo H, Zayzafoon M. NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone 2009;45:579-89.
17. Situ D, Long H, Lin P, Zhu Z, Wang J, Zhang X, et al. Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma. J Cancer Res Clin Oncol 2010;136:1213-9.
18. Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, et al. beta2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res 2011;71:2600-10.
19. Wu MT, Wu RH, Hung CF, Cheng TL, Tsai WH, Chang WT. Simple and efficient DNA vector-based RNAi systems in mammalian cells. Bio-chem Biophys Res Commun 2005;330:53-9.
20. DuBois S, Demetri G. Markers of angiogenesis and clinical features in patients with sarcoma. Cancer 2007;109:813-9. (Pubitemid 46333523)
21. Fink CC, Bayer KU, Myers JW, Ferrell JE Jr, Schulman H, Meyer T. Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron 2003;39:283-97. (Pubitemid 36897550)
22. Wheeler DG, Barrett CF, Groth RD, Safa P, Tsien RW. CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation-transcription coupling. J Cell Biol 2008;183:849-63.
23. Lu KK, Armstrong SE, Ginnan R, Singer HA. Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle. Am J Physiol Cell Physiol 2005;289:C1343-50.
24. Wang Y, Simonson MS. Voltage-insensitive Ca2+ channels and Ca2+/calmodulin-dependent protein kinases propagate signals from endothelin-1 receptors to the c-fos promoter. Mol Cell Biol 1996;16: 5915-23. (Pubitemid 26315113)
25. Franco L, Zocchi E, Usai C, Guida L, Bruzzone S, Costa A, et al. Paracrine roles of NAD+ and cyclic ADP-ribose in increasing intra-cellular calcium and enhancing cell proliferation of 3T3 fibroblasts. J Biol Chem 2001;276:21642-8.
26. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997;386:855-8. (Pubitemid 27181262)
27. Zhao X, Wang D, Zhao Z, Xiao Y, Sengupta S, Zhang R, et al. Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells. J Biol Chem 2006;281:29357-68. (Pubitemid 44507079)
28. Chakrabarty S, Radjendirane V, Appelman H, Varani J. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Cancer Res 2003;63: 67-71. (Pubitemid 36070421)
29. Roderick HL, Cook SJ. Ca2 +signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer 2008;8:361-75. (Pubitemid 351589702)
30. Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, et al. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. Embo J 2006;25:3714-24. (Pubitemid 44264881)
31. Rhim JS, Cho HY, Vernon ML, Arnstein P, Huebner RJ, Gilden RV. Characterization of non-producer human cells induced by Kirsten sarcoma virus. Int J Cancer 1975;16:840-9.
32. Rhim JS, Park DK, Arnstein P, Huebner RJ, Weisburger EK, Nelson-Rees WA. Transformation of human cells in culture by N-methyl-N′-nitro-N- nitrosoguanidine. Nature 1975;256:751-3.
33. Rhim JS. Neoplastic transformation of human cells in vitro. Crit Rev Oncog 1993;4:313-35.
34. Lemieux M, Labrecque S, Tardif C, Labrie-Dion E, Lebel E, De Koninck P. Translocation of CaMKII to dendritic microtubules supports the plasticity of local synapses. J Cell Biol 198:1055-73.
35. Xiao C, Yang BF, Asadi N, Beguinot F, Hao C. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem 2002;277:25020-5. (Pubitemid 34951805)
36. Rokhlin OW, Guseva NV, Taghiyev AF, Glover RA, Cohen MB. KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer. Cancer Biol Ther 9:224-35.
37. Lee KH. CaMKII inhibitor KN-62 blunts tumor response to hypoxia by inhibiting HIF-1a in hepatoma cells. Korean J Physiol Pharmacol 14:331-6.
38. Wu GY, Deisseroth K, Tsien RW. Activity-dependent CREB phosphor-ylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 2001;98:2808-13. (Pubitemid 32209565)
39. Funakoshi Y, Ichiki T, Takeda K, Tokuno T, Iino N, Takeshita A. Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 2002;277:18710-7. (Pubitemid 34952428)
40. Premkumar DR, Mishra RR, Overholt JL, Simonson MS, Cherniack NS, Prabhakar NR. L-type Ca(2+) channel activation regulates induction of c-fos transcription by hypoxia. J Appl Physiol 2000;88:1898-906.
41. Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S, Williams BR. Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. EMBO J 2001;20:2487-96. (Pubitemid 32452867)
42. Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, Edwards DR, et al. The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J Biol Chem 2003;278:10304-13. (Pubitemid 36800292)
43. Knesaurek K. Two new experimental methods of calculating scatter fractionasafunctionofdepthinscattering media:acomparison study. Med Phys 1992;19:591-8.
44. Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, et al. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PLoS ONE 5:e10456.
45. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.